BMY

3 High-Quality Health Care Companies With Recession-Proof Dividends

By Bob Ciura, Sure Dividend
Health care companies may not be at the front of mind when thinking of stocks with dividends, but these three are winners.

7 Retirement Stocks to Buy to Supplement Your 401k

By Bret Kenwell, InvestorPlace Contributor
Picking retirement stocks isn't an easy thing to do. We need some growth, but yield is nice too. Above all, we need dependable. Let's explore.

4 Top Stock Trades for Thursday: AMZN, SPOT, BMY, ABBV

By Bret Kenwell, InvestorPlace Contributor
Amazon, Spotify, Bristol-Myers Squibb and AbbVie were our top stock trades for Thursday. Let's look at the charts of these earnings movers.

7 Pharmaceutical Stocks With Compelling Pipelines

By Chris Lau, InvestorPlace Contributor
Covid-19 vaccines are getting all the glory after multi-bagger returns last year but these seven pharmaceutical stocks have a strong future ahead.

7 Pharmaceutical Stocks With Exciting Plans for 2021

By Bret Kenwell, InvestorPlace Contributor
Pharmaceutical stocks have many benefits, particularly when their products are in demand. And in 2021, that seems likely to be the case.

The Top 7 Pharmaceutical Stocks for the Next 10 Years 

By Alex Sirois, InvestorPlace Contributor
Pharmaceutical stocks can be a great investment in a unique niche of the market. The stocks on this list will be strong for a decade plus.

7 Cheap Stocks to Buy in January For a Quick Buck

By Alex Sirois, InvestorPlace Contributor
2020 has taken the market capitalizations of many strong companies to lows. That means there are some great options for cheap stocks to buy in January.

7 Cheap Stocks That Can’t Wait for 2021 

By Bret Kenwell, InvestorPlace Contributor
Cheap stocks have always intrigued investors because we always want a bargain. So, here are seven cheap stocks to buy now.

7 Undervalued Stocks to Buy Now

By Bret Kenwell, InvestorPlace Contributor
Everyone is on the hunt for undervalued stocks. Keep in mind, even more highly valued stocks can be undervalued. Let's look at seven of them.

3 Cheap Dividend Stocks For High Total Returns

By Bob Ciura, Sure Dividend
Cheap dividend stocks can generate a double dose of returns, with dividends as well as capital appreciation through a rising share price.

7 Pharmaceutical Stocks to Buy for 2021 and Beyond 

By Bret Kenwell, InvestorPlace Contributor
Pharmaceutical stocks help make the world go round. Without them, common ailments would plague our lives. With them, we can solve Covid-19.

7 Healthcare Stocks That Can Survive Massive Reform

By Tezcan Gecgil, InvestorPlace Contributor
These seven healthcare stocks may represent robust long-term investments no matter how reforms in the sector may develop post-election.

7 Cutting-Edge Biotech Stocks for Tomorrow 

By Bret Kenwell, InvestorPlace Contributor
Biotech stocks are always going to be here, in good times and bad. Let's look at a few that are worth considering on the long side.

M&A News: MyoKardia (MYOK) Stock Soars on Bristol Myers Squibb Deal

By Nick Clarkson, Web Editor
MyoKardia's major, $13.1 billon deal with fellow pharmaceutical company Bristol Myers Squibb sent MYOK stock soaring on Monday.

This Company is the Landlord of Life Sciences

By Neil George
Alexandria Real Estate Equities is the largest landlord in the US for laboratories and related offices.

5 Top Stock Trades for Friday: UBER, FB, BMY, MU, TWLO

By Bret Kenwell, InvestorPlace Contributor
Bristol-Myers Squibb, Uber, Facebook, Micron and Twilio were our top stock trades for Friday. That said, let's look at the charts now.

Bristol-Myers Squibb Earnings: BMY Stock Jumps 2% on Q2 Beats

By Nick Clarkson, Web Editor
Bristol-Myers Squibb earnings on Thursday have BMY stock rising higher after the company beat EPS and revenue estimates from Wall Street.

Bristol-Myers Squibb Is a Dirt-Cheap Buy Before Earnings

By David Moadel, InvestorPlace Contributor
Thanks to its Celgene acquisition, Bristol-Myers Squibb looks attractive ahead of earnings. Here's why you should buy BMY stock.

Bristol-Myers Squibb Has Great Potential Ahead of Earnings

By Mark R. Hake, CFA
Ahead earnings, Bristol-Myers Squibb is a great value play. In fact, BMY stock is worth 30%-70% more than its current share price.
Load More